AmSurg Reports Second-Quarter Adjusted Diluted EPS of $0.97 and Diluted EPS of $0.65
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Piper Jaffray Raises Price Target on Amsurg (AMSG) to $82 Following 2Q EPS Beat
August 5, 2015 9:47 AM EDTPiper Jaffray reiterated an Overweight rating on AmSurg (NASDAQ: AMSG), and raised the price target to $82.00 (from $72.00), following 2Q results. Revenues increased 131% y/y to $642M, which was $29M higher than consensus of $613M. Adjusted EPS of $0.97 was $0.13 higher than consensus of $0.84.
Analyst... More
Amsurg (AMSG) Tops Q2 EPS by 13c, Raises FY Guidance
August 4, 2015 4:02 PM EDTAmsurg (NASDAQ: AMSG) reported Q2 EPS of $0.97, $0.13 better than the analyst estimate of $0.84. Revenue for the quarter came in at $642 million versus the consensus estimate of $613.55 million.
Amsurg sees Q3 2015 EPS of $0.92-$0.95, versus the consensus of $0.89.
Amsurg sees FY2015 EPS of... More
